Non-small cell lung cancer
Conditions
Interventions
Sponsors
Shanghai Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A total of 136 patients with lung cancer were hospitalized in the Department of Oncology, Shanghai traditional Chinese Medicine Hospital from October 2021 to May 2023. (1) all cases were confirmed by pathology or cytology as stage III b and IV non-small cell lung cancer (NSCLC). (2) less than 75 years of age. (3) the estimated survival time is more than 3 months. (4) General condition PS <= 2. (5) have the indication of chemotherapy. (6) stop using other anticancer drugs for more than one month before being selected for observation; patients who have been ineffective in the third-line treatment of western medicine before. (7) the patient has good knowledge and compliance. The lung cancer staging standard adopts the revised international staging of lung cancer published by the International Federation for Lung Cancer Research (International Association for the Study of Lung Cancer, IASLC) in 2007.
Exclusion criteria
Exclusion criteria: (1) Failure to take drugs in accordance with the regulations. (2) Those who are unable to judge the curative effect, or whose data are incomplete and affect the judgment of the curative effect. (3) Patients with severe impairment of heart, liver and kidney function. (4) Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation standard of curative effect of solid tumor;Survival period;TCM syndrome;Quality of life score;Pain score; | — |
Countries
China
Contacts
Public ContactFang Zhihong
Shanghai Traditional Chinese Medicine Hospital
Outcome results
None listed